Synchrocyclotron

Global Radiation Therapy in the Oncology Market (2021 to 2031) - Featuring Accuray, Elekta and General Electric Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, August 9, 2021
Radiology, Health, Oncology, Zap, CAGR, Diagnosis, Siemens, ICAD Inc., Hitachi, Cancer, Synchrocyclotron, HDR, Radiation, Industry, Proton, Growth, Patient, Varian Medical Systems, Synchrotron, Oncology, Safety, Photon, LINAC, General Electric Company, Cyclotron, Medical imaging, Pharmaceutical industry

Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation.

Key Points: 
  • Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation.
  • The term 'radiation therapy' mostly refers to external beam radiation therapy, but it also means internal beam radiation therapy too.
  • What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?
  • What was the market value of the leading segments of the global radiation therapy in oncology market in 2020?

Synchrocyclotron for the MEVION S250i Proton Therapy System Delivered to Huntsman Cancer Institute

Retrieved on: 
Wednesday, April 1, 2020
Oncology, Education, Health, Medical devices, Radiology, Continuing, University, Medical physics, Academic disciplines, Physical sciences, Health, Radiobiology, Radioactivity, Proton, Proton therapy, Synchrocyclotron, Radiation therapy, Therapy, Ionizing radiation

Mevion Medical Systems announced today that it has delivered the synchrocyclotron accelerator for the MEVION S250i Proton Therapy System to Huntsman Cancer Institute (HCI) at the University of Utah (U of U) on March 28, 2020.

Key Points: 
  • Mevion Medical Systems announced today that it has delivered the synchrocyclotron accelerator for the MEVION S250i Proton Therapy System to Huntsman Cancer Institute (HCI) at the University of Utah (U of U) on March 28, 2020.
  • By reducing the size and complexity of a proton therapy system, Mevion has allowed hospitals to offer proton therapy without the enormous expenditures and space requirements needed by other single-room or multi-room proton systems.
  • Today, more cancer centers are considering providing compact proton therapy to their patients because of the technology Mevion has advanced.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%

Retrieved on: 
Tuesday, November 27, 2018
Accelerator physics, Physics, Radiation therapy, Medical physics, Health, Medicine, Particle accelerators, Particle physics, Particle therapy, Cyclotron, Synchrotron, Synchrocyclotron

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.

Key Points: 
  • The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.
  • The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.
  • Based on type, the particle therapy products market is segmented into cyclotrons, synchrotrons, and synchrocyclotrons.The cyclotrons segment is expected to account for the largest share of this market in 2018.
  • On the basis of application, the particle therapy market has been segmented into treatment and research applications.

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%

Retrieved on: 
Monday, November 26, 2018
Accelerator physics, Physics, Cyclotron, Synchrotron, Synchrocyclotron, Compound annual growth rate

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.

Key Points: 
  • The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.
  • Based on type, the particle therapy products market is segmented into cyclotrons, synchrotrons, and synchrocyclotrons.The cyclotrons segment is expected to account for the largest share of this market in 2018.
  • On the basis of application, the particle therapy market has been segmented into treatment and research applications.
  • The particle therapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.North America is expected to account for the second-largest share of the global particle therapy market in 2018.